title: Reply to Levis and Rendini.
authors.affiliation: Special Centre for Molecular Medicine, Jawaharlal Nehru University, and.|International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
authors.forename: Dhiraj Kumar
authors.initials: DK
authors.lastname: Singh
authors.affiliation: Special Centre for Molecular Medicine, Jawaharlal Nehru University, and.|International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
authors.forename: Ved Prakash
authors.initials: VP
authors.lastname: Dwivedi
authors.affiliation: Special Centre for Molecular Medicine, Jawaharlal Nehru University, and.|International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
authors.forename: Anand
authors.initials: A
authors.lastname: Ranganathan
authors.affiliation: Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; and.
authors.forename: William R
authors.initials: WR
authors.lastname: Bishai
authors.affiliation: Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee.
authors.forename: Luc
authors.initials: L
authors.lastname: Van Kaer
authors.affiliation: Special Centre for Molecular Medicine, Jawaharlal Nehru University, and.
authors.forename: Gobardhan
authors.initials: G
authors.lastname: Das
mesh_terms: D002991:Clofazimine; D006678:HIV; D006801:Humans; D009161:Mycobacterium; D009369:Neoplasms
chemical_list: D002991:Clofazimine